Nemaura Medical Inc., to present sugarBEAT® Poster at the Advanced Technologies and Treatments for Diabetes Symposium (ATTD) in Paris, February 16th 2017
Nemaura Pharma secures funding to advance its Micro-Patch™ solid dose microneedle system for a hormone Biologic
They're only meant to be a one-day holding, and during that period you're just guessing.
ETFs offer a number of benefits, but that does not mean we can ignore investing fundamentals.
Yield-hungry investors also loaded up on junk bonds, while rate hike fears push fixed-income investors to the short end of the yield curve.
Sometimes the simplest solution is the best.